Hexapeptide-10 | CAS:146439-94-3

We serve Hexapeptide-10 CAS:146439-94-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Hexapeptide-10

Chemical Name:Hexapeptide-10
CAS.NO:146439-94-3
Synonyms:Hexapeptide-10
L-Seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-L-valine
Serilesine
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 1012.5±65.0 °C at 760 mmHg
Molecular Formula C28H53N7O8
Molecular Weight 615.763
Flash Point 566.1±34.3 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.522
 
Specification:
Appearance:White powder
Assay:≥95%
Moisture:≤5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hexapeptide-10 is a synthetic peptide containing Alanine, Isoleucine, Lysine, Serine and Valine residues. It increases the synthesis of laminin V and α6-integrin to promote cell binding, with extraordinary visible skin restructuring and firming abilities.



Contact us for information like Hexapeptide-10 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Serilesine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-L-valine Use and application,Serilesine technical grade,usp/ep/jp grade.


Related News: At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.benzyl isothiocyanate manufacturer At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.Sulfur dichloride supplier But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.4-Thiazolecarboxylic Acid vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients.